Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: EMD 521873 in Advanced Solid Tumors, MTD Finding [Phase 1]
Phase 1 study evaluating the maximum tolerated dose and safety of EMD 521873 in patients with Non-Hodgkin lymphoma; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture [Phase 4]
This document reports the completion of a Phase 4 trial evaluating EMLA cream and/or nitrous oxide for analgesia in pediatric patients durin…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 1]
This update describes a Phase 1 trial of a combination chemotherapy regimen in children with advanced Non-Hodgkin lymphoma or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial by the Children's Oncology Group evaluated less-intensive therapy for children with Non-Hodgkin lymphoma; the study status i…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for pediatric patients with advanced-stage large cell lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD [Phase 2]
Phase 2 trial update evaluating low-dose interleukin-2 in patients undergoing allogeneic hematopoietic stem cell transplantation to address …
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease [Phase 1]
This document reports the completion of a Phase 1 safety and efficacy study of CNTO-328 (siltuximab) in patients with B-cell non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
Completed a clinical trial evaluating Non-Hodgkin lymphoma in patients over 80 years old in the Rituximab era. The update summarizes the stu…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 study evaluating cyclophosphamide as the sole graft-versus-host disease prophylaxis after allogeneic stem cell transplantation has c…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma [Phase 2]
Phase 2 trial comparing pegfilgrastim with filgrastim for mobilized blood stem cell collection in patients with non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This clinical trial reports results for using 90Y-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen before allogeneic…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study [Phase 2]
Phase 2 trial update of brentuximab vedotin in patients who previously participated in a brentuximab vedotin study, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial of noscapine in patients with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukemia refractory to chemot…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating elsamitrucin (SPP 28090) in patients with relapsed or refractory Non-Hodgkin's Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating Velcade (bortezomib) in combination with rituximab for relapsed/refractory mantle cell lymphoma and follicular no…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine (SDX-105) for safety and activity in patients with rituximab-refractory non-Hodgkin lymphoma; the stud…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Phase 2 trial evaluating SDX-105 in combination with Rituxan for relapsed indolent or mantle cell Non-Hodgkin's Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood [Phase 1, Phase 2]
Phase 1/2 trial evaluating Wilms' Tumor 1 protein vaccine for blood cancers has completed. Results were posted on 2014-05-08.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]
Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas [Phase 2]
This is a Phase 2 clinical trial update for relapsed or refractory diffuse large B-cell non-Hodgkin lymphoma that has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study [Phase 3]
Phase 3 trial comparing bendamustine plus rituximab to R-CVP or R-CHOP in first-line advanced indolent non-Hodgkin's lymphoma or mantle cell…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody [Phase 2]
Phase 2 trial evaluating retreatment of non-Hodgkin lymphoma patients who previously responded to iodine-131 anti-B1 antibody; results were …